Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance

Zhongwei Cao, Bi Sen Ding, Peipei Guo, Sharrell B. Lee, Jason M. Butler, Stephanie C. Casey, Michael Simons, Wayne Tam, Dean W. Felsher, Koji Shido, Arash Rafii Tabrizi, Joseph M. Scandura, Shahin Rafii

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Tumor endothelial cells (ECs) promote cancer progression in ways beyond their role as conduits supporting metabolism. However, it is unknown how vascular niche-derived paracrine factors, defined as angiocrine factors, provoke tumor aggressiveness. Here, we show that FGF4 produced by B cell lymphoma cells (LCs) through activating FGFR1 upregulates the Notch ligand Jagged1 (Jag1) on neighboring ECs. In turn, upregulation of Jag1 on ECs reciprocally induces Notch2-Hey1 in LCs. This crosstalk enforces aggressive CD44+IGF1R+CSF1R+ LC phenotypes, including extranodal invasion and chemoresistance. Inducible EC-selective deletion of Fgfr1 or Jag1 in the Eμ-Myc lymphoma model or impairing Notch2 signaling in mouse and human LCs diminished lymphoma aggressiveness and prolonged mouse survival. Thus, targeting the angiocrine FGF4-FGFR1/Jag1-Notch2 loop inhibits LC aggressiveness and enhances chemosensitivity.

Original languageEnglish
Pages (from-to)350-365
Number of pages16
JournalCancer Cell
Volume25
Issue number3
DOIs
Publication statusPublished - 17 Mar 2014
Externally publishedYes

Fingerprint

B-Cell Lymphoma
Blood Vessels
Lymphoma
Endothelial Cells
Neoplasms
Up-Regulation
Ligands
Phenotype

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Cao, Z., Ding, B. S., Guo, P., Lee, S. B., Butler, J. M., Casey, S. C., ... Rafii, S. (2014). Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell, 25(3), 350-365. https://doi.org/10.1016/j.ccr.2014.02.005

Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. / Cao, Zhongwei; Ding, Bi Sen; Guo, Peipei; Lee, Sharrell B.; Butler, Jason M.; Casey, Stephanie C.; Simons, Michael; Tam, Wayne; Felsher, Dean W.; Shido, Koji; Tabrizi, Arash Rafii; Scandura, Joseph M.; Rafii, Shahin.

In: Cancer Cell, Vol. 25, No. 3, 17.03.2014, p. 350-365.

Research output: Contribution to journalArticle

Cao, Z, Ding, BS, Guo, P, Lee, SB, Butler, JM, Casey, SC, Simons, M, Tam, W, Felsher, DW, Shido, K, Tabrizi, AR, Scandura, JM & Rafii, S 2014, 'Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance', Cancer Cell, vol. 25, no. 3, pp. 350-365. https://doi.org/10.1016/j.ccr.2014.02.005
Cao, Zhongwei ; Ding, Bi Sen ; Guo, Peipei ; Lee, Sharrell B. ; Butler, Jason M. ; Casey, Stephanie C. ; Simons, Michael ; Tam, Wayne ; Felsher, Dean W. ; Shido, Koji ; Tabrizi, Arash Rafii ; Scandura, Joseph M. ; Rafii, Shahin. / Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. In: Cancer Cell. 2014 ; Vol. 25, No. 3. pp. 350-365.
@article{81e87dcc0f6c4b0d982f1a8d366ddcb2,
title = "Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance",
abstract = "Tumor endothelial cells (ECs) promote cancer progression in ways beyond their role as conduits supporting metabolism. However, it is unknown how vascular niche-derived paracrine factors, defined as angiocrine factors, provoke tumor aggressiveness. Here, we show that FGF4 produced by B cell lymphoma cells (LCs) through activating FGFR1 upregulates the Notch ligand Jagged1 (Jag1) on neighboring ECs. In turn, upregulation of Jag1 on ECs reciprocally induces Notch2-Hey1 in LCs. This crosstalk enforces aggressive CD44+IGF1R+CSF1R+ LC phenotypes, including extranodal invasion and chemoresistance. Inducible EC-selective deletion of Fgfr1 or Jag1 in the Eμ-Myc lymphoma model or impairing Notch2 signaling in mouse and human LCs diminished lymphoma aggressiveness and prolonged mouse survival. Thus, targeting the angiocrine FGF4-FGFR1/Jag1-Notch2 loop inhibits LC aggressiveness and enhances chemosensitivity.",
author = "Zhongwei Cao and Ding, {Bi Sen} and Peipei Guo and Lee, {Sharrell B.} and Butler, {Jason M.} and Casey, {Stephanie C.} and Michael Simons and Wayne Tam and Felsher, {Dean W.} and Koji Shido and Tabrizi, {Arash Rafii} and Scandura, {Joseph M.} and Shahin Rafii",
year = "2014",
month = "3",
day = "17",
doi = "10.1016/j.ccr.2014.02.005",
language = "English",
volume = "25",
pages = "350--365",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance

AU - Cao, Zhongwei

AU - Ding, Bi Sen

AU - Guo, Peipei

AU - Lee, Sharrell B.

AU - Butler, Jason M.

AU - Casey, Stephanie C.

AU - Simons, Michael

AU - Tam, Wayne

AU - Felsher, Dean W.

AU - Shido, Koji

AU - Tabrizi, Arash Rafii

AU - Scandura, Joseph M.

AU - Rafii, Shahin

PY - 2014/3/17

Y1 - 2014/3/17

N2 - Tumor endothelial cells (ECs) promote cancer progression in ways beyond their role as conduits supporting metabolism. However, it is unknown how vascular niche-derived paracrine factors, defined as angiocrine factors, provoke tumor aggressiveness. Here, we show that FGF4 produced by B cell lymphoma cells (LCs) through activating FGFR1 upregulates the Notch ligand Jagged1 (Jag1) on neighboring ECs. In turn, upregulation of Jag1 on ECs reciprocally induces Notch2-Hey1 in LCs. This crosstalk enforces aggressive CD44+IGF1R+CSF1R+ LC phenotypes, including extranodal invasion and chemoresistance. Inducible EC-selective deletion of Fgfr1 or Jag1 in the Eμ-Myc lymphoma model or impairing Notch2 signaling in mouse and human LCs diminished lymphoma aggressiveness and prolonged mouse survival. Thus, targeting the angiocrine FGF4-FGFR1/Jag1-Notch2 loop inhibits LC aggressiveness and enhances chemosensitivity.

AB - Tumor endothelial cells (ECs) promote cancer progression in ways beyond their role as conduits supporting metabolism. However, it is unknown how vascular niche-derived paracrine factors, defined as angiocrine factors, provoke tumor aggressiveness. Here, we show that FGF4 produced by B cell lymphoma cells (LCs) through activating FGFR1 upregulates the Notch ligand Jagged1 (Jag1) on neighboring ECs. In turn, upregulation of Jag1 on ECs reciprocally induces Notch2-Hey1 in LCs. This crosstalk enforces aggressive CD44+IGF1R+CSF1R+ LC phenotypes, including extranodal invasion and chemoresistance. Inducible EC-selective deletion of Fgfr1 or Jag1 in the Eμ-Myc lymphoma model or impairing Notch2 signaling in mouse and human LCs diminished lymphoma aggressiveness and prolonged mouse survival. Thus, targeting the angiocrine FGF4-FGFR1/Jag1-Notch2 loop inhibits LC aggressiveness and enhances chemosensitivity.

UR - http://www.scopus.com/inward/record.url?scp=84896098492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896098492&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2014.02.005

DO - 10.1016/j.ccr.2014.02.005

M3 - Article

VL - 25

SP - 350

EP - 365

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 3

ER -